ArticleFrontiers in pharmacology2026

Tirzepatide versus other glucose-lowering therapies and risk of COPD exacerbations in patients with comorbid type 2 diabetes: a retrospective cohort study.

Wan-Hsuan Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.